Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota

Y Zhang, P Tan, Y Zhao, X Ma - Gut Microbes, 2022 - Taylor & Francis
Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea in children and
travelers in develo** countries. ETEC is characterized by the ability to produce major …

Childhood diarrhoeal diseases in develo** countries

HU Ugboko, OC Nwinyi, SU Oranusi, JO Oyewale - Heliyon, 2020 - cell.com
Diarrhoeal diseases collectively constitute a serious public health challenge globally,
especially as the leading cause of death in children (after respiratory diseases). Childhood …

[HTML][HTML] Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access

I Khalil, R Walker, CK Porter, F Muhib, R Chilengi… - Vaccine, 2021 - Elsevier
Diarrhoeal disease attributable to enterotoxigenic Escherichia coli (ETEC) causes
substantial morbidity and mortality predominantly in paediatric populations in low-and …

Controlled human infection models to accelerate vaccine development

RKM Choy, AL Bourgeois… - Clinical Microbiology …, 2022 - Am Soc Microbiol
The timelines for develo** vaccines against infectious diseases are lengthy, and often
vaccines that reach the stage of large phase 3 field trials fail to provide the desired level of …

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

KR Talaat, C Alaimo, P Martin, AL Bourgeois… - …, 2021 - thelancet.com
Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …

[HTML][HTML] Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)

I Khalil, JD Anderson, KH Bagamian, S Baqar… - Vaccine, 2023 - Elsevier
Enterotoxigenic Escherichia coli (ETEC) is one of the leading bacterial causes of diarrhoea,
especially among children in low-resource settings, and travellers and military personnel …

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study

JD Anderson, KH Bagamian, CJ Pecenka… - The Lancet Global …, 2023 - thelancet.com
Background Vaccine impact and cost-effectiveness models have mostly focused on acute
burden. Shigella-attributable moderate-to-severe diarrhoea has been shown to be …

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised …

F Qadri, M Akhtar, TR Bhuiyan… - The Lancet Infectious …, 2020 - thelancet.com
Summary Background Enterotoxigenic Escherichia coli causes diarrhoea, leading to
substantial mortality and morbidity in children, but no specific vaccine exists. This trial tested …

[HTML][HTML] Vaccine value profile for Shigella

WP Hausdorff, JD Anderson IV, KH Bagamian… - Vaccine, 2023 - Elsevier
Shigella is the leading bacterial cause of diarrhoea and the second leading cause of
diarrhoeal mortality among all ages. It also exhibits increasing levels of antibiotic resistance …

Diarrhea Case Surveillance in the Enterics for Global Health Shigella Surveillance Study: Epidemiologic Methods

HE Atlas, B Conteh, MT Islam, KC Jere… - Open Forum …, 2024 - academic.oup.com
Background Shigella is a leading cause of acute watery diarrhea, dysentery, and diarrhea-
attributed linear growth faltering, a precursor to stunting and lifelong morbidity. Several …